Reach Us +1-504-608-2390
Tina Guanting Qiu | OMICS International
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Tina Guanting Qiu

Tina Guanting Qiu Dr. Tina Guanting Qiu
Biopharma Physician Consultant (independent)
Peabody MA


Tina Guanting Qiu is an accomplished ophthalmology physician, trained retinal surgeon, stem cell biologist, and ocular transplant specialist with over 20 years of international experience. She had led scientific research in drug discovery, drug delivery and cell/gene therapy, established and led scientific and medical advisory boards, and served as a strategic advisor to executives in large and small companies (Inotek, LambdaVision, Sucampo, Ocata, GLG). She was Chief Medical Officer at BetaStem Inc., Senior Director at Inotekand Program Leader at GlaxoSmithKline. She has a Medical Doctor degree (with honors) from Nanchang University, a PhD in Ophthalmology from National Sun Yat-sen University in collaboration with Sheie Eye Institute, UPenn followed by post-doctoral trainings at Boston University and Doheny Eye Institute, USC. She has developed, published and lectured across US, UK, Japan and China, and been featured at Scientific American and National Eye Research Center, UK.

Research Interest

clinical development (protocol synopsis, high level content strategy, adaptive clinical trials), early stage clinical translation (preclinical studies, bridge gaps, and IND package design), late stage clinical translation (disease staging, safety and efficacy integration, NDA review and regulatory labeling), commercial medical affairs (KOLs leadership, medical communications, market messages, and medical training and support)


Global Speakers in the subject

Global Experts in the subject